ARID1A and carcinoma: Loss of the ARID1A gene has been reported to be associated with poor prognosis in a variety of tumors [26–28], and a study on EC published in 2021 also showed that TP53wt/NSMP carcinomas harboring ARID1A mutations were more likely to relapse [29].